Szukaj
Wyświetlanie pozycji 1-3 z 3
Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer
(Springer Open Journal, 2022)
The significance of Akkermansia bacteria presence in gut micobiome, mainly Akkermansia mucinifila, is currently being investigated in the context of supporting therapy and marker for response to immunotherapy in cancer ...
Probiotic Potential of Clostridium spp.—Advantages and Doubts
(MDPI, 2022)
Clostridium spp. is a large genus of obligate anaerobes and is an extremely heterogeneous
group of bacteria that can be classified into 19 clusters. Genetic analyses based on the next-
generation sequencing of 16S rRNA ...
Attempting to identify bacterial allies in immunotherapy of NSCLC patients
(MDPI, 2022)
Introduction: Factors other than PD-L1 (Programmed Death Ligand 1) are being sought
as predictors for cancer immuno- or chemoimmunotherapy in ongoing studies and long-term ob-
servations. Despite high PD-L1 expression ...